In one paragraphArticle in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Ana María Castañeda-Cifuentesde Investigación e Innovación Biomédica GI2B, Facultad de Ciencias Exactas y Aplicadas, Institución Universitaria ITM, Medellín 050012, Colombia.ORCID 0000-0002-7082-211X Johanna Pedroza-Díazde Investigación e Innovación Biomédica GI2B, Facultad de Ciencias Exactas y Aplicadas, Institución Universitaria ITM, Medellín 050012, Colombia.ORCID 0000-0002-9784-874X Gloria A Santa-Gonzálezde Investigación e Innovación Biomédica GI2B, Facultad de Ciencias Exactas y Aplicadas, Institución Universitaria ITM, Medellín 050012, Colombia.ORCID 0000-0003-0514-5957 Isabel Cristina Henao-CastañedaGrupo de Investigación en Sustancias Bioactivas, Facultad de Ciencias Farmacéuticas y Alimentarias, Universidad de Antioquia, Medellín 050010, Colombia.ORCID 0000-0003-1893-2191 Andrea Johanna Andrea BáezGrupo de Investigación en Sustancias Bioactivas, Facultad de Ciencias Farmacéuticas y Alimentarias, Universidad de Antioquia, Medellín 050010, Colombia.
Jorge L JiosLaboratorio UPL (UNLP-CIC), Camino Centenario e/505 y 508 (1897) M.B. Gonnet, Departamento de Química, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, República Argentina, 47 esq. 115, La Plata 1900, Buenos Aires, Argentina.ORCID 0000-0001-7812-0043 Ana Laura Di VirgilioCentro de Química Inorgánica (CEQUINOR, CONICET), Facultad de Ciencias Exactas, Universidad Nacional de la Plata Facultad, 47 Y 115, La Plata 1900, Buenos Aires, Argentina.
Funding
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2MInstitución Universitaria ITM P23203NIGMS NIH HHS R01 GM129325
6 · The paper itselfAbstract
Chlorogenic acid (CGA) exhibits anticancer activity in colorectal cancer (CRC), but its clinical application is limited by low lipophilicity. To improve its physicochemical properties, four CGA esters (methyl, ethyl,
Indexed as
Antineoplastic AgentsChlorogenic AcidColorectal NeoplasmsEstersApoptosisCell Line, TumorCell ProliferationCell SurvivalHT29 CellsHumansHydrophobic and Hydrophilic InteractionsMolecular Docking SimulationStructure-Activity RelationshipAntineoplastic AgentsChlorogenic AcidEsterscell deathchlorogenic acidchlorogenic acid esterscolorectal canceresterificationn-butyl chlorogenateoxidative stress
Identifiers
PMID42738613
PMCPMC13567004
What Socratic holds
Textmetadata
Read underepoch 390